Caxton Associates (New York)’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-34,432
| Closed | -$1.97M | – | 565 |
|
|
2024
Q3 | $1.97M | Buy |
34,432
+9,000
| +35% | +$515K | 0.07% | 119 |
|
|
2024
Q2 | $1.33M | Buy |
+25,432
| New | +$1.33M | 0.05% | 206 |
|
|
2024
Q1 | – | Sell |
-8,281
| Closed | -$306K | – | 501 |
|
|
2023
Q4 | $306K | Buy |
+8,281
| New | +$306K | 0.02% | 398 |
|
|
2023
Q2 | – | Sell |
-13,035
| Closed | -$498K | – | 559 |
|
|
2023
Q1 | $498K | Buy |
+13,035
| New | +$498K | 0.08% | 261 |
|
|
2022
Q3 | – | Sell |
-9,782
| Closed | -$430K | – | 541 |
|
|
2022
Q2 | $430K | Buy |
+9,782
| New | +$430K | 0.04% | 297 |
|
|
2021
Q1 | – | Sell |
-10,471
| Closed | -$447K | – | 414 |
|
|
2020
Q4 | $447K | Buy |
+10,471
| New | +$447K | 0.03% | 49 |
|
|
2020
Q3 | – | Sell |
-49,216
| Closed | -$1.32M | – | 385 |
|
|
2020
Q2 | $1.32M | Buy |
+49,216
| New | +$1.32M | 0.12% | 48 |
|
|
2020
Q1 | – | Sell |
-32,348
| Closed | -$574K | – | 472 |
|
|
2019
Q4 | $574K | Buy |
+32,348
| New | +$574K | 0.08% | 142 |
|